CUT'HIVAC
Project background
The CUT’HIVAC project is an innovative needle-free vaccination strategy across the skin to combat HIV and other infectious diseases.
Funded by the European Commision under the 7th Framework Programme the collaboration spans 5 years and involves 13 partners across Europe, Africa, and South America.
The consortium combines expertise in HIV vaccine development, including DNA-GTU® and particle-based technologies, together with novel skin and mucosal routes of vaccine delivery, as well as pre-clinical, dermatological and clinical trials knowledge.
The CUT’HIVAC project is made possible by a team of dedicated international scientists based at the Université Pierre & Marie Curie in Paris, France.
The Project Coordinator is Béhazine Combadiere. Behazine Combadiere is a director of research at Inserm U945/UPMC and has extensive experience on vaccination for infectious disease and skin immunology.